Cartesian Therapeutics Inc. (RNAC) Stock Price, Quote & News

Cartesian Therapeutics In... (RNAC)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

18.68

0.08%

After-hours Dec 13, 2024, 04:00 PM EST

undefined% (undefined)

Bid	18.33
Market Cap	474.50M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-55.43
PE Ratio (ttm)	-0.34
Forward PE	n/a
Shares Out	25.41M
Short % of Shares Out	undefined%

Ask	23
Volume	70,772
Open	19.90
Previous Close	20.12
Day's Range	18.14 - 20.71
52-Week Range	11.66 - 41.87
Beta	undefined
Shares Float	-
Short % of Float	undefined%

About RNAC

undefined

[Show more]

Industry -

Sector -

IPO Date n/a

Employees NaN

Stock Exchange -

Ticker Symbol RNAC

Website -

Analyst Forecast

According to 0 analyst ratings, the average rating for RNAC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Buy 0%

Hold 0%

Sell 0%

Stock Forecasts

Why Price Moved

News

No News article available yet